Graham Number Checker

Date Checked2026-02-19 22:17:47
Graham Number(PB)22.14 vs (PE)35.92
Over / Under Value Percentage123.10% vs 60.88%
Dividend Yield3.01%
Dividend Date2025-08-26
SymbolNVO
AssetTypeCommon Stock
NameNovo Nordisk A/S
DescriptionNovo Nordisk A/S (NVO) is a leading global healthcare company based in Bagsvaerd, Denmark, specializing in diabetes care, obesity treatment, and hormone replacement therapies. Renowned for its innovation and commitment to rigorous scientific research, Novo Nordisk utilizes advanced biotechnology to develop high-quality pharmaceutical products that address chronic disease management. As a pivotal player in the biopharmaceutical sector, the company focuses on improving patient outcomes while emphasizing sustainability and ethical business practices.
CIK353278
ExchangeNYSE
CurrencyUSD
CountryUSA
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - GENERAL
AddressNOVO ALLE 1, BAGSVAERD, DENMARK, 2880
OfficialSitehttps://www.novonordisk.com
FiscalYearEndDecember
LatestQuarter2025-09-30
MarketCapitalization254789124000
EBITDA165492998000
PERatio15.71
PEGRatio2.451
BookValue5.97
DividendPerShare11.65
EPS3.65
RevenuePerShareTTM71.0
ProfitMargin0.329
OperatingMarginTTM0.444
ReturnOnAssetsTTM0.211
ReturnOnEquityTTM0.715
RevenueTTM315602993000
GrossProfitTTM263334003000
DilutedEPSTTM3.65
QuarterlyEarningsGrowthYOY-0.265
QuarterlyRevenueGrowthYOY0.051
AnalystTargetPrice54.73
AnalystRatingStrongBuy1
AnalystRatingBuy5
AnalystRatingHold4
AnalystRatingSell2
AnalystRatingStrongSell0
TrailingPE15.71
ForwardPE16
PriceToSalesRatioTTM0.807
PriceToBookRatio9.6
EVToRevenue5.43
EVToEBITDA11.36
Beta0.358
52WeekHigh91.28
52WeekLow43.08
50DayMovingAverage49.4
200DayMovingAverage59.43
SharesOutstanding3368607000
SharesFloat3187974000
PercentInsiders0.003
PercentInstitutions9.104
ExDividendDate2025-08-18
dateChecked2026-02-19 22:17:47
fresh1